PMGC HOLDINGS INC (ELAB)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$5.21-0.38%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · ELAB
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenues | — | 0.6 | — | 1.7 | 0.8 | — |
| Total Revenues | — | 0.6 | — | 1.7 | 0.8 | — |
| Cost of Revenues | — | 0.4 | — | 0.6 | 0.3 | — |
| Gross Profit | — | 0.2 | — | 1.1 | 0.4 | — |
| Operating Expenses & Income | ||||||
| R&D Expenses | 0.4 | 0.1 | 0.1 | 0.0 | 0.2 | — |
| Other Operating Expenses, Total | — | — | 11.9 | 4.2 | 1.6 | — |
| Earnings from Continuing Operations | ||||||
| Interest Expense | — | 0.3 | 0.7 | 0.0 | 0.0 | — |
| Interest & Investment Income | 0.2 | 0.1 | 0.0 | 0.0 | — | — |
| Net Interest Expenses | — | — | — | 0.0 | — | — |
| Other Non-Operating Income / Expenses | — | — | — | (3.8) | (1.8) | — |
| EBT, Incl. Unusual Items | — | (7.7) | — | — | — | — |
| Income Tax Expense | — | 0.0 | — | — | — | — |
| Net Income | ||||||
| Net Income | (13.5) | (7.7) | (6.2) | (4.3) | (1.8) | — |
| Per Share | ||||||
| Basic EPS | (2.77) | — | — | (0.40) | (0.19) | — |
| Diluted EPS | — | — | — | (0.40) | (0.19) | — |
| Basic Weighted Avg Shares | 4.9 | 0.0 | 0.1 | 0.0 | 9.5 | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.